🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: iv dexamethasone

Found 1373 matching trials

A Korean Study of Efficacy and Safety of Aprepitant-based Triple Regimen for the Prevention of Chemotherapy-Induced Nausea and Vomiting in the First Cycle of Moderately Emetogenic Chemotherapy (Non-doxorubicin Hydrochloride [Adriamycin] and Cyclophosphamide Regimens) (MK-0869-225) (KMEC)

PHASE4

This is an efficacy and safety study to compare aprepitant with ondansetron...

Status

Completed

Location

Multiple Locations

Start Date

2012-12-12

Trial ID

NCT01636947

Treatments Being Tested

Aprepitant Aprepitant Placebo Ondansetron Dexamethasone Ondansetron Placebo Rescue Therapy (granisetron, dolasetron, tropisetron or ondansetron; metoclopramide or alizapride).

Study of Pembrolizumab (MK-3475) Plus Docetaxel Versus Placebo Plus Docetaxel in Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-921/KEYNOTE-921)

PHASE3

The purpose of this study is to assess the efficacy and safety of the combi...

Status

Completed

Location

University of South Alabama, Mitchell Cancer Institute ( Site 0065)

Start Date

2019-05-02

Trial ID

NCT03834506

Treatments Being Tested

Pembrolizumab Docetaxel Prednisone Placebo Dexamethasone

Ketofol Versus Propofol for Sedation in Cholangiopancreatography for ASA III and ASA IV Patients.

This study is a double blind randomized controlled trial. The investigators...

Status

Completed

Location

Multiple Locations

Start Date

2016-10-01

Trial ID

NCT05473949

Treatments Being Tested

Profofol for Sedation in Cholangiopancreatography for ASA III and ASA IV Patients Ketofol for Sedation in Cholangiopancreatography for ASA III and ASA IV Patients

MesomiR 1: A Phase I Study of TargomiRs as 2nd or 3rd Line Treatment for Patients With Recurrent MPM and NSCLC

PHASE1

The first testing of TargomiRs in the human setting: dose-finding studies i...

Status

Completed

Location

Concord Repatriation General Hospital

Start Date

2014-09

Trial ID

NCT02369198

Treatments Being Tested

TargomiRs

A Study of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) Alone or in Combination With an Immunomodulatory Drug and/or Daratumumab in Participants With Multiple Myeloma (MM)

PHASE1

This multicenter, open-label, Phase I study will evaluate the safety, effic...

Status

Completed

Location

University of Alabama at Birmingham

Start Date

2015-07-22

Trial ID

NCT02431208

Treatments Being Tested

Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody Daratumumab Lenalidomide Pomalidomide Dexamethasone

Spinal Versus General Anesthesia With Popliteal and Adductor Canal Blocks for Ambulatory Foot and Ankle Surgery.

PHASE4

The purpose of this study is to determine if there is a difference in patie...

Status

Completed

Location

Hospital for Special Surgery, New York

Start Date

2017-01

Trial ID

NCT02996591

Treatments Being Tested

25 mL of 0.25% bupivacaine plus 2 mg preservative-free (PF) dexamethasone / 30 ml for popliteal nerve block 10 mL of 0.25% bupivacaine plus 2 mg preservative-free (PF) dexamethasone / 30 ml for adductor canal nerve block Midazolam, 2-5 mg IV + Glycopyrrolate, 0.1 mg IV + Ketamine, 10-20 mg + propofol as needed 45-60 mg of 1.5% mepivacaine for spinal anesthesia LMA insertion + titrated propofol infusion + sevoflurane + ketamine 10 mg/hr for general anesthesia

Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)

PHASE3

The primary objective of the study is to compare sacituzumab tirumotecan co...

Status

Recruiting

Location

Mayo Clinic in Arizona - Phoenix ( Site 0147)

Start Date

2023-12-15

Trial ID

NCT06170788

Treatments Being Tested

Sacituzumab tirumotecan Pembrolizumab Supportive care measures

Daratumumab (HuMax®-CD38) Safety Study in Multiple Myeloma

PHASE2

Establishment of safety profile of HuMax-CD38 when given as monotherapy in ...

Status

Completed

Location

Multiple Locations

Start Date

2008-03-26

Trial ID

NCT00574288

Treatments Being Tested

Part 1: Daratumumab Part 2: Daratumumab Methylprednisolone Dexamethasone

Ixazomib Citrate, Lenalidomide, Dexamethasone, and Zoledronic Acid or Zoledronic Acid Alone After Radiation Therapy in Treating Patients With Solitary Plasmacytoma of Bone

PHASE3

This randomized phase III trial compares ixazomib citrate, lenalidomide, de...

Status

Terminated

Location

Anchorage Associates in Radiation Medicine

Start Date

2016-11-29

Trial ID

NCT02516423

Treatments Being Tested

ixazomib lenalidomide dexamethasone zoledronic acid

Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer

PHASE3

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...

Status

Completed

Location

CCOP - Cedar Rapids Oncology Project

Start Date

1996-01

Trial ID

NCT00002716

Treatments Being Tested

dexamethasone floxuridine fluorouracil leucovorin calcium laparotomy conventional surgery

Previous Next